142 related articles for article (PubMed ID: 2245840)
1. A novel regimen of gonadotropin-releasing hormone (GnRH) antagonist plus pulsatile GnRH: controlled restoration of gonadotropin secretion and ovulation induction.
Gordon K; Williams RF; Danforth DR; Hodgen GD
Fertil Steril; 1990 Dec; 54(6):1140-5. PubMed ID: 2245840
[TBL] [Abstract][Full Text] [Related]
2. Single-dose administration of the gonadotropin-releasing hormone antagonist, Nal-Lys (antide) to healthy men.
Bagatell CJ; Conn PM; Bremner WJ
Fertil Steril; 1993 Oct; 60(4):680-5. PubMed ID: 8405525
[TBL] [Abstract][Full Text] [Related]
3. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
Couzinet B; Young J; Brailly S; Chanson P; Schaison G
J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the antigonadotropic activity of three GnRH antagonists (Nal-Glu, Antide and Cetrorelix) in a non-human primate model (Macaca fascicularis).
Weinbauer GF; Nieschlag E
Andrologia; 1993; 25(3):141-7. PubMed ID: 8517553
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
[TBL] [Abstract][Full Text] [Related]
6. Potent pituitary-gonadal axis suppression and extremely low anaphylactoid activity of a new gonadotropin releasing hormone (GnRH) receptor antagonist "azaline B".
Campen CA; Lai MT; Kraft P; Kirchner T; Phillips A; Hahn DW; Rivier J
Biochem Pharmacol; 1995 May; 49(9):1313-21. PubMed ID: 7763313
[TBL] [Abstract][Full Text] [Related]
7. New trends in combined use of gonadotropin-releasing hormone antagonists with gonadotropins or pulsatile gonadotropin-releasing hormone in ovulation induction and assisted reproductive technologies.
Gordon K; Danforth DR; Williams RF; Hodgen GD
Curr Opin Obstet Gynecol; 1992 Oct; 4(5):690-6. PubMed ID: 1391640
[TBL] [Abstract][Full Text] [Related]
8. Probing studies on multiple dose effects of antide (Nal-Lys) GnRH antagonist in ovariectomized monkeys.
Leal JA; Gordon K; Williams RF; Danforth DR; Roh SI; Hodgen GD
Contraception; 1989 Nov; 40(5):623-33. PubMed ID: 2515029
[TBL] [Abstract][Full Text] [Related]
9. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of pituitary gonadotropin secretion by the gonadotropin-releasing hormone antagonist antide. II. Development of an in vitro bioassay for characterization of pharmacokinetics and pharmacodynamics of antide in circulation.
Danforth DR; Williams RF; Gordon K; Leal JA; Hodgen GD
Endocrinology; 1991 Apr; 128(4):2041-4. PubMed ID: 1900785
[TBL] [Abstract][Full Text] [Related]
11. Ovulation inhibition by administration of weekly gonadotropin-releasing hormone antagonist.
Kenigsberg D; Hodgen GD
J Clin Endocrinol Metab; 1986 Apr; 62(4):734-8. PubMed ID: 3081571
[TBL] [Abstract][Full Text] [Related]
12. Antide-induced suppression of pituitary gonadotropin and ovarian steroid secretion in cynomolgus monkeys: premature luteolysis and prolonged inhibition of folliculogenesis following single treatment.
Gordon K; Williams RF; Danforth DR; Hodgen GD
Biol Reprod; 1991 Apr; 44(4):701-6. PubMed ID: 2043741
[TBL] [Abstract][Full Text] [Related]
13. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
Filicori M; Flamigni C; Meriggiola MC; Ferrari P; Michelacci L; Campaniello E; Valdiserri A; Cognigni G
J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487
[TBL] [Abstract][Full Text] [Related]
14. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
Fraser HM; Nestor JJ; Vickery BH
Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
[TBL] [Abstract][Full Text] [Related]
15. Suppression of plasma gonadotropins and testosterone in adult male monkeys (Macaca fascicularis) by a potent inhibitory analog of gonadotropin-releasing hormone.
Adams LA; Bremner WJ; Nestor JJ; Vickery BH; Steiner RA
J Clin Endocrinol Metab; 1986 Jan; 62(1):58-63. PubMed ID: 3079603
[TBL] [Abstract][Full Text] [Related]
16. Variable ovarian response to gonadotropin-releasing hormone antagonist-induced gonadotropin deprivation during different phases of the menstrual cycle.
Fluker MR; Marshall LA; Monroe SE; Jaffe RB
J Clin Endocrinol Metab; 1991 Apr; 72(4):912-9. PubMed ID: 2005218
[TBL] [Abstract][Full Text] [Related]
17. Human follicle-stimulating hormone exerts a stimulatory effect on spermatogenesis, testicular size, and serum inhibin levels in the gonadotropin-releasing hormone antagonist-treated nonhuman primate (Macaca fascicularis).
Weinbauer GF; Behre HM; Fingscheidt U; Nieschlag E
Endocrinology; 1991 Oct; 129(4):1831-9. PubMed ID: 1915071
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human follicle-stimulating hormone stimulates multiple follicular growth, but minimal estrogen production in gonadotropin-releasing hormone antagonist-treated monkeys: examining the role of luteinizing hormone in follicular development and steroidogenesis.
Karnitis VJ; Townson DH; Friedman CI; Danforth DR
J Clin Endocrinol Metab; 1994 Jul; 79(1):91-7. PubMed ID: 8027261
[TBL] [Abstract][Full Text] [Related]
19. The gonadotropin-releasing hormone (GnRH) agonist-induced initial rise of bioactive LH and testosterone can be blunted in a dose-dependent manner by GnRH antagonist in the non-human primate.
Sharma OP; Weinbauer GF; Behre HM; Nieschlag E
Urol Res; 1992; 20(5):317-21. PubMed ID: 1455564
[TBL] [Abstract][Full Text] [Related]
20. Suppression of ovarian estradiol secretion by a single injection of antide in cynomolgus monkeys during the early follicular phase: immediate, sustained, and reversible actions.
Gordon K; Williams RF; Danforth DR; Conn PM; Hutchison JS; Hodgen GD
J Clin Endocrinol Metab; 1991 Dec; 73(6):1262-8. PubMed ID: 1955507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
